Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Injury|March 10, 2005
Secondary effects of femoral instrumentation on pulmonary physiology in a standardised sheep model: what is the effect of lung contusion and reaming?Frank Hildebrand, Peter Giannoudis, Martijn van Griensven, et al.Anesthesiology|December 1, 1990
Halothane alters the oxygen consumption-oxygen delivery relationship compared with conscious stateP Rock, C Beattie, A W Kimball, et al.Physical Review Letters|April 16, 2013
Atomic structure of interface states in silicon heterojunction solar cellsB M George, J Behrends, A Schnegg, et al.Revue Medicale Suisse|June 14, 2008
[Laparoscopy in the management of endometrial cancer]P Petignat, D Stucki, H-J Altermatt, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2017
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial DiagnosisJeannette Fischer, Claudia Paret, Khalifa El Malki, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2010
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)C Rochlitz, T Ruhstaller, S Lerch, et al.Hematological Oncology|December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandA A Moccia, S Aeppli, S Güsewell, et al.Geburtshilfe Und Frauenheilkunde|September 27, 2016
Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)K J Neis, W Zubke, T Römer, et al.Leukemia|July 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndromeJ J W M Janssen, B Löwenberg, M Manz, et al.Leukemia|February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDSG J Ossenkoppele, D A Breems, G Stuessi, et al.Pageof 11